Dataset_ID	Sample_ID	Platform_ID	age	distant_metastasis	er_status	intratumoral_lymphocytic_infiltration	nodes_positive	pgr_status	stromal_lymphocytic_infiltration	time_to_ddfs	tissue	treatment	tumor_size
GSE58984	GSM1423346	GPL570	42	0	1	0	3	0	3	3645	HER2 breast cancer tumor	trastuzumab	60
GSE58984	GSM1423347	GPL570	49	0	0	0	0	0	1	3729	HER2 breast cancer tumor	trastuzumab	18
GSE58984	GSM1423348	GPL570	43	0	1	0	1	1	3	3517	HER2 breast cancer tumor	trastuzumab	11
GSE58984	GSM1423349	GPL570	69	1	1	3	13	0	25	1062	HER2 breast cancer tumor	trastuzumab	15
GSE58984	GSM1423350	GPL570	68	0	0	0	0	0	10	3125	HER2 breast cancer tumor	trastuzumab	30
GSE58984	GSM1423351	GPL570	68	1	1	0	NA	1	3	880	HER2 breast cancer tumor	trastuzumab	NA
GSE58984	GSM1423352	GPL570	37	0	1	1	1	1	60	2786	HER2 breast cancer tumor	trastuzumab	10
GSE58984	GSM1423353	GPL570	52	1	0	0	0	0	20	2117	HER2 breast cancer tumor	trastuzumab	50
GSE58984	GSM1423354	GPL570	50	0	1	1	0	1	20	2562	HER2 breast cancer tumor	trastuzumab	45
GSE58984	GSM1423355	GPL570	33	0	0	1	5	0	7	914	HER2 breast cancer tumor	trastuzumab	35
GSE58984	GSM1423356	GPL570	60	0	1	0	3	1	1	2544	HER2 breast cancer tumor	trastuzumab	55
GSE58984	GSM1423357	GPL570	54	0	0	0	0	0	5	2665	HER2 breast cancer tumor	trastuzumab	30
GSE58984	GSM1423358	GPL570	56	1	0	5	2	1	30	1000	HER2 breast cancer tumor	trastuzumab	23
GSE58984	GSM1423359	GPL570	64	0	1	1	0	0	7	2397	HER2 breast cancer tumor	trastuzumab	45
GSE58984	GSM1423360	GPL570	40	1	0	0	8	0	10	279	HER2 breast cancer tumor	trastuzumab	40
GSE58984	GSM1423361	GPL570	45	0	1	3	0	1	17	2252	HER2 breast cancer tumor	trastuzumab	55
GSE58984	GSM1423362	GPL570	52	0	1	0	0	1	15	2315	HER2 breast cancer tumor	trastuzumab	17
GSE58984	GSM1423363	GPL570	36	0	0	0	0	0	3	2420	HER2 breast cancer tumor	trastuzumab	26
GSE58984	GSM1423364	GPL570	38	0	1	0	1	1	5	2155	HER2 breast cancer tumor	trastuzumab	15
GSE58984	GSM1423365	GPL570	49	0	1	0	7	1	2	2541	HER2 breast cancer tumor	trastuzumab	50
GSE58984	GSM1423366	GPL570	54	0	1	1	1	1	25	2223	HER2 breast cancer tumor	trastuzumab	10
GSE58984	GSM1423367	GPL570	49	0	0	1	4	0	7	2495	HER2 breast cancer tumor	trastuzumab	25
GSE58984	GSM1423368	GPL570	48	0	1	0	2	0	5	2170	HER2 breast cancer tumor	trastuzumab	73
GSE58984	GSM1423369	GPL570	35	0	1	5	4	1	30	2267	HER2 breast cancer tumor	trastuzumab	20
GSE58984	GSM1423370	GPL570	65	0	0	3	0	0	51	2218	HER2 breast cancer tumor	trastuzumab	23
GSE58984	GSM1423371	GPL570	73	1	0	1	28	0	7	1124	HER2 breast cancer tumor	trastuzumab	70
GSE58984	GSM1423372	GPL570	69	0	1	1	0	1	7	2272	HER2 breast cancer tumor	trastuzumab	22
GSE58984	GSM1423373	GPL570	43	0	1	0	0	1	30	2161	HER2 breast cancer tumor	trastuzumab	19
GSE58984	GSM1423374	GPL570	68	0	1	0	0	0	3	1689	HER2 breast cancer tumor	trastuzumab	32
GSE58984	GSM1423375	GPL570	70	0	1	0	1	1	0	921	HER2 breast cancer tumor	trastuzumab	35
GSE58984	GSM1423376	GPL570	61	0	1	0	0	1	2	2201	HER2 breast cancer tumor	trastuzumab	19
GSE58984	GSM1423377	GPL570	35	0	1	1	0	1	10	2219	HER2 breast cancer tumor	trastuzumab	22
GSE58984	GSM1423378	GPL570	66	0	0	0	0	0	3	2216	HER2 breast cancer tumor	trastuzumab	44
GSE58984	GSM1423379	GPL570	45	0	1	0	1	1	10	2180	HER2 breast cancer tumor	trastuzumab	37
GSE58984	GSM1423380	GPL570	56	0	0	0	1	0	1	2304	HER2 breast cancer tumor	trastuzumab	55
GSE58984	GSM1423381	GPL570	49	1	0	0	1	0	0	876	HER2 breast cancer tumor	trastuzumab	55
GSE58984	GSM1423382	GPL570	55	0	0	1	0	0	12	1846	HER2 breast cancer tumor	trastuzumab	23
GSE58984	GSM1423383	GPL570	54	1	1	1	0	1	25	966	HER2 breast cancer tumor	trastuzumab	35
GSE58984	GSM1423384	GPL570	43	0	1	5	0	0	51	1845	HER2 breast cancer tumor	trastuzumab	25
GSE58984	GSM1423385	GPL570	48	0	1	0	2	0	0	1985	HER2 breast cancer tumor	trastuzumab	35
GSE58984	GSM1423386	GPL570	51	0	1	0	2	1	3	1774	HER2 breast cancer tumor	trastuzumab	60
GSE58984	GSM1423387	GPL570	67	0	0	1	1	0	51	1943	HER2 breast cancer tumor	trastuzumab	20
GSE58984	GSM1423388	GPL570	56	0	0	0	4	0	15	1896	HER2 breast cancer tumor	trastuzumab	15
GSE58984	GSM1423389	GPL570	62	0	0	0	0	0	5	1139	HER2 breast cancer tumor	trastuzumab	25
GSE58984	GSM1423390	GPL570	55	1	1	0	5	1	7	1297	HER2 breast cancer tumor	trastuzumab	32
GSE58984	GSM1423391	GPL570	68	0	1	0	0	1	3	1993	HER2 breast cancer tumor	trastuzumab	13
GSE58984	GSM1423392	GPL570	50	0	1	1	1	1	30	701	HER2 breast cancer tumor	trastuzumab	31
GSE58984	GSM1423393	GPL570	70	0	0	0	16	0	3	1748	HER2 breast cancer tumor	trastuzumab	30
GSE58984	GSM1423394	GPL570	53	0	1	0	0	1	2	903	HER2 breast cancer tumor	trastuzumab	20
GSE58984	GSM1423395	GPL570	54	0	1	1	6	1	51	788	HER2 breast cancer tumor	trastuzumab	30
GSE58984	GSM1423396	GPL570	51	0	0	10	0	0	60	1892	HER2 breast cancer tumor	trastuzumab	15
GSE58984	GSM1423397	GPL570	51	0	1	0	0	1	15	1629	HER2 breast cancer tumor	trastuzumab	40
GSE58984	GSM1423398	GPL570	68	0	1	0	0	1	3	1822	HER2 breast cancer tumor	trastuzumab	18
GSE58984	GSM1423399	GPL570	53	0	0	0	1	0	5	1810	HER2 breast cancer tumor	trastuzumab	77
GSE58984	GSM1423400	GPL570	52	0	0	1	1	0	25	1757	HER2 breast cancer tumor	trastuzumab	28
GSE58984	GSM1423401	GPL570	41	0	0	3	1	0	45	1668	HER2 breast cancer tumor	trastuzumab	35
GSE58984	GSM1423402	GPL570	53	0	0	0	1	0	3	1921	HER2 breast cancer tumor	trastuzumab	33
GSE58984	GSM1423403	GPL570	43	0	0	0	0	0	2	1430	HER2 breast cancer tumor	trastuzumab	19
GSE58984	GSM1423404	GPL570	45	0	1	0	1	1	2	1666	HER2 breast cancer tumor	trastuzumab	24
GSE58984	GSM1423405	GPL570	77	0	1	0	4	1	1	1780	HER2 breast cancer tumor	trastuzumab	45
GSE58984	GSM1423406	GPL570	54	0	0	3	2	0	10	1637	HER2 breast cancer tumor	trastuzumab	56
GSE58984	GSM1423407	GPL570	64	0	1	1	1	1	2	1726	HER2 breast cancer tumor	trastuzumab	22
GSE58984	GSM1423408	GPL570	34	0	1	0	2	0	3	1735	HER2 breast cancer tumor	trastuzumab	25
GSE58984	GSM1423409	GPL570	55	0	1	1	0	1	30	1820	HER2 breast cancer tumor	trastuzumab	25
GSE58984	GSM1423410	GPL570	47	0	1	0	0	1	3	1521	HER2 breast cancer tumor	trastuzumab	15
GSE58984	GSM1423411	GPL570	40	0	1	0	0	0	5	1774	HER2 breast cancer tumor	trastuzumab	50
GSE58984	GSM1423412	GPL570	72	0	0	1	1	0	5	1421	HER2 breast cancer tumor	trastuzumab	19
GSE58984	GSM1423413	GPL570	53	0	1	3	2	1	25	1453	HER2 breast cancer tumor	trastuzumab	49
GSE58984	GSM1423414	GPL570	52	0	1	0	0	0	3	1408	HER2 breast cancer tumor	trastuzumab	45
GSE58984	GSM1423415	GPL570	49	0	1	0	0	0	0	1539	HER2 breast cancer tumor	trastuzumab	17
GSE58984	GSM1423416	GPL570	49	0	1	0	0	1	10	1518	HER2 breast cancer tumor	trastuzumab	14
GSE58984	GSM1423417	GPL570	44	0	1	1	6	1	10	1492	HER2 breast cancer tumor	trastuzumab	40
GSE58984	GSM1423418	GPL570	79	0	1	0	0	1	3	1498	HER2 breast cancer tumor	trastuzumab	18
GSE58984	GSM1423419	GPL570	52	0	1	0	0	1	3	1457	HER2 breast cancer tumor	trastuzumab	25
GSE58984	GSM1423420	GPL570	57	0	1	0	6	1	10	1610	HER2 breast cancer tumor	trastuzumab	25
GSE58984	GSM1423421	GPL570	57	0	1	0	0	1	3	1508	HER2 breast cancer tumor	trastuzumab	20
GSE58984	GSM1423422	GPL570	39	0	1	0	0	0	1	1469	HER2 breast cancer tumor	trastuzumab	37
GSE58984	GSM1423423	GPL570	45	0	1	0	0	1	7	1483	HER2 breast cancer tumor	trastuzumab	20
GSE58984	GSM1423424	GPL570	49	0	1	1	12	1	3	1388	HER2 breast cancer tumor	trastuzumab	45
GSE58984	GSM1423425	GPL570	45	0	1	5	11	1	95	1372	HER2 breast cancer tumor	trastuzumab	24
GSE58984	GSM1423426	GPL570	68	0	0	1	1	0	10	1312	HER2 breast cancer tumor	trastuzumab	22
GSE58984	GSM1423427	GPL570	49	1	0	1	2	0	10	660	HER2 breast cancer tumor	trastuzumab	45
GSE58984	GSM1423428	GPL570	65	0	0	1	0	0	7	1175	HER2 breast cancer tumor	trastuzumab	23
GSE58984	GSM1423429	GPL570	52	1	0	0	8	0	2	201	HER2 breast cancer tumor	trastuzumab	22
GSE58984	GSM1423430	GPL570	42	0	0	0	18	0	3	2621	HER2 breast cancer tumor	trastuzumab	13
GSE58984	GSM1423431	GPL570	38	0	1	0	5	1	3	3077	HER2 breast cancer tumor	trastuzumab	28
GSE58984	GSM1423432	GPL570	57	0	0	1	3	0	10	1492	HER2 breast cancer tumor	trastuzumab	55
GSE58984	GSM1423433	GPL570	48	0	1	0	1	1	2	1012	HER2 breast cancer tumor	trastuzumab	17
GSE58984	GSM1423434	GPL570	61	0	1	0	0	0	2	2000	HER2 breast cancer tumor	trastuzumab	20
GSE58984	GSM1423435	GPL570	41	0	1	0	1	1	5	1723	HER2 breast cancer tumor	trastuzumab	30
GSE58984	GSM1423436	GPL570	71	0	0	0	0	0	2	1471	HER2 breast cancer tumor	trastuzumab	45
GSE58984	GSM1423437	GPL570	40	0	1	1	0	1	5	1459	HER2 breast cancer tumor	trastuzumab	21
GSE58984	GSM1423438	GPL570	49	0	1	15	12	0	70	470	HER2 breast cancer tumor	trastuzumab	52
GSE58984	GSM1423439	GPL570	49	0	1	0	0	1	3	844	HER2 breast cancer tumor	trastuzumab	16
